|
Q1 FY2027
As of Jul 31, 2026
|
Q4 FY2026
As of Apr 24, 2026
|
Q3 FY2026
As of Jan 23, 2026
|
Q2 FY2026
As of Oct 24, 2025
|
Q1 FY2026
As of Jul 25, 2025
|
Q4 FY2025
As of Apr 25, 2025
|
Q3 FY2025
As of Jan 24, 2025
|
Q2 FY2025
As of Oct 25, 2024
|
Q1 FY2025
As of Jul 26, 2024
|
Q4 FY2024
As of Apr 26, 2024
|
Q3 FY2024
As of Jan 26, 2024
|
Q2 FY2024
As of Oct 27, 2023
|
Q1 FY2024
As of Jul 28, 2023
|
Q4 FY2023
As of Apr 28, 2023
|
Q3 FY2023
As of Jan 27, 2023
|
Q2 FY2023
As of Oct 28, 2022
|
Q1 FY2023
As of Jul 29, 2022
|
Q4 FY2022
As of Apr 29, 2022
|
Q3 FY2022
As of Jan 28, 2022
|
Q2 FY2022
As of Oct 29, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Short-term investments | ||||||||||||||||||||
| Accounts receivable | ||||||||||||||||||||
| Inventories | ||||||||||||||||||||
| Other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Purchased intangible assets, net | ||||||||||||||||||||
| Other non-current assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued expenses | ||||||||||||||||||||
| Current portion of long-term debt | ||||||||||||||||||||
| Short-term deferred revenue | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Long-term debt | ||||||||||||||||||||
| Other long-term liabilities | ||||||||||||||||||||
| Long-term deferred revenue | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Stockholders' equity: | ||||||||||||||||||||
| Preferred stock, $0.001 par value, 5 shares authorized; no shares issued or outstanding as of April 25, 2025 or April 26, 2024 | ||||||||||||||||||||
| Common stock and additional paid-in capital, $0.001 par value, 885 shares authorized; 196 shares issued and outstanding as of July 31, 2026 and April 24, 2026 | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Total stockholders' equity | ||||||||||||||||||||
| Total liabilities and stockholders' equity | ||||||||||||||||||||
Loading...
